This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Artificial tears

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • Most ocular lubricants may be purchased over the counter from a pharmacy at a cost less than the current prescription charge

  • Hypromellose is the first line choice. The standard preparation is 0.3% and may be administered up to every hour if required

  • Unpreserved hypromellose is a pharmaceutical special and should only be used where there is a proven allergy to or toxicity from preservative. It has an expiry of 1 week after opening. Other single use lubricating eye drops are available e.g. carmellose sodium 1% (Celluvisc®)

  • Lacri-Lube® is included as a lubricating eye ointment. It may be used in combination with artificial tear drops and applied at night

  • Lacri-Lube® contains lanolin-wool fat derivatives.

  • Liquifilm®/SnoTears® and Viscotears®/GelTears® are included as useful second line agents

  • Viscotears®/GelTears are thicker preparations and are used three to four times daily

  • Preservative-free preparations of lubricants should be prescribed if used more than QDS regularly

  • Sodium hyaluronate and Hydroxypropyl Guar are more expensive than other ocular lubricants but maybe more cost effective for patients who do not use an entire bottle every month as the drops remain sterile in the bottle for 6 months after opening.

Reference:


Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.